Archives
CD36 Lipid Signaling Drives AML Immune Escape
2026-09-23
This 2024 Cell Reports Medicine study identifies a non-canonical CD36 lipid-sensing program that enables acute myeloid leukemia cells to suppress T-cell activity and resist decitabine-associated immune effects. Its central insight is that oxidized LDL and palmitate cooperate through innate immune signaling rather than lipid oxidation alone, while statin-mediated lipid restriction can improve decitabine efficacy in experimental AML models.
HCAR3 Agonist Selectivity Revealed by Cryo-EM
2026-09-22
Ye et al. resolve cryo-EM structures of HCAR3 and HCAR2 bound to several agonists, including Acifran, and identify pocket features that govern ligand recognition and receptor selectivity. The findings connect receptor sequence differences with functional cAMP signaling and provide a structural framework for lipid metabolism regulation and HCAR3-focused drug discovery.
Pemetrexed Assays: From Folate Stress to Repair
2026-09-22
Pemetrexed disodium is more than a broad cytotoxic control: it can help researchers connect folate-dependent nucleotide stress with DNA-repair phenotypes. This guide presents an assay-centered framework for interpreting pemetrexed responses in lung cancer and mesothelioma models.
VE-822 ATR Inhibitor for DDR Assays
2026-09-21
VE-822 is a potent, selective ATR inhibitor for dissecting replication-stress signaling and improving cancer chemoradiotherapy studies. This practical guide connects PDAC radiosensitization workflows with patient-derived iPSC assay design while separating established evidence from translational hypotheses.
N-octanoyl-L-Homoserine lactone Workflows
2026-09-21
Use N-octanoyl-L-Homoserine lactone to model quorum-sensing control of biofilms, bacterial virulence, and host-cell responses with defined dosing. This guide translates the latest C8-HSL cancer-biology findings into practical assay design, controls, and troubleshooting decisions.
YZ462 Disrupts MRSA Membranes: Study Insights
2026-09-19
The 2025 BMC Microbiology study identifies YZ462 as a heteroaromatic-aryl small molecule that acts against methicillin-resistant Staphylococcus aureus by damaging the bacterial membrane, increasing permeability, and inducing endogenous reactive oxygen species. Its activity across growth states and biofilms, together with in vivo efficacy, supports further investigation while the cardiolipin interaction provides a mechanistic direction for future optimization.
From Ferroptosis to Immune Control with IL-2
2026-09-18
Carbon-ion radiotherapy may do more than damage gastric cancer cells: emerging evidence links it to DHODH suppression, ferroptosis, and M1-like macrophage polarization. This article translates that mechanistic signal into a practical validation strategy and positions IL-2, human recombinant as a controlled variable for testing whether radiation-shaped immune environments can be made functionally productive.
Recombinant Human IL-6 in Blastoid Assays
2026-09-18
Recombinant Human IL-6, Tag Free provides a controlled cytokine perturbation for exploring how inflammatory signaling may intersect with WDR36-dependent glycolysis and trophectoderm differentiation in human blastoid models.
JXY, TLR4, and M1 Polarization in CAC
2026-09-17
Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like phenotype through TLR4-associated signaling. The study combines an orthotopic disease model with histology, immunohistochemistry, macrophage functional assays, and pharmacologic pathway perturbation to connect immune polarization with tumor progression.
Rhamnolipid-Stabilized mRNA Nanovaccines
2026-09-17
The reference study develops PEG-free lipid nanoparticles in which microbial rhamnolipids provide both colloidal stabilization and intrinsic immune stimulation. Its experiments associate rhamnolipid-containing particles with dendritic-cell targeting, lymph-node-biased expression, stronger Th1 and cytotoxic T-cell responses, and reduced mast-cell infiltration during repeat dosing.
BODIPY 581/591 C11: Reliable Lipid Peroxidation
2026-09-16
Learn how BODIPY 581/591 C11 (SKU C8003) supports ratiometric lipid peroxidation detection, oxidative stress measurement, and comparative antioxidant capacity evaluation in live-cell and membrane workflows. This scenario-based guide covers assay design, spectral interpretation, protocol optimization, and practical vendor selection.
RNA Pol II Inhibition and Active Apoptotic Signaling
2026-09-16
Harper and colleagues show that RNA polymerase II inhibition kills cells through an actively regulated apoptotic response rather than through passive loss of transcription, mRNA, or protein. Their functional-genomic and rescue experiments identify loss of hypophosphorylated RNA Pol IIA as the initiating signal and define a Pol II degradation-dependent apoptotic response with implications for cancer biology and drug-mechanism interpretation.
VX-765 for Caspase-1 and Pyroptosis Studies
2026-09-15
VX-765 provides a selective way to connect caspase-1 activity with IL-1β and IL-18 release, pyroptotic death, and inflammatory phenotypes. This practical workflow shows how to apply it in endothelial, macrophage, autoimmune, and infectious-disease models while separating pathway-specific effects from general cytotoxicity.
VX-765 Workflow for Caspase-1 Inflammation Studies
2026-09-15
VX-765 enables selective interrogation of caspase-1-dependent cytokine release, pyroptosis, and barrier injury across biochemical, cellular, and preclinical workflows. This guide translates the compound’s prodrug biology into practical assay design, with troubleshooting guidance for macrophage, blood-brain barrier, rheumatoid arthritis, and infectious-disease studies.
Radicicol: A Mechanistic Assay Guide
2026-09-14
Radicicol is an Hsp90 inhibitor with a broader experimental profile spanning adipocyte differentiation, apoptosis, kinase ATP-site biology, and inflammation. This guide shows how to use the compound as a mechanistic perturbation tool while distinguishing its validated actions from the non-canonical thermogenesis findings reported for hyperforin.